Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC Science Clips
COVID-10 GPH

Last data update: Dec 09, 2024. (Total: 48320 publications since 2009)
(Author names in bold with hyperlink are CDC authors)
Filtered By:
Order By:
Records 1-2 (of 2 Records)
Query Trace: Varella L[original query]
Establishing Best Practices in a Response to an HIV Cluster: An Example from a Surge Response in West Virginia.
Quilter L , Agnew-Brune C , Broussard D , Salmon M , Bradley H , Hogan V , Ridpath A , Burton K , Rose BC , Kirk N , Reynolds P , Varella L , Granado M , Gerard A , Thompson A , De La Garza G , Lee C , Bernstein K .
Sex Transm Dis 2020 48 (3) e35-e40 type type

Increases in injection drug use (IDU) as a result of increasing levels of opioid misuse in the United States may increase risk for new, rapidly transmitted HIV infections in communities with otherwise low HIV prevalence.1 Changing characteristics and geographic locations of persons at risk for HIV infection due to injection-related risk behavior present ongoing challenges to partner services for HIV prevention. These jurisdictions have historically had less need for HIV-related partner services and therefore less investment in HIV outbreak preparedness and prevention infrastructure. Jurisdictions with low HIV prevalence have also had to rely on cluster investigation methods that were developed for primary use in urban areas. In early 2019, the US strategic plan to end the HIV epidemic in the United States within 10 years was announced, which prioritizes the rapid detection and response to emerging clusters of HIV infection to further reduce new transmissions as 1 of the 4 main pillars of the initiative.2
Increased HIV diagnoses in West Virginia counties highly vulnerable to rapid HIV dissemination through injection drug use: a cautionary tale
Bradley H , Hogan V , Agnew-Brune C , Armstrong J , Broussard D , Buchacz K , Burton K , Cope S , Dawson E , De La Garza G , Gerard A , Granado M , Gupta R , Haddy L , Hoffman W , Johnson SD , Kirk N , Lee C , Lyss S , Mark-Carew M , Quilter L , Reynolds P , Rose B , Thompson A , Varella L , Weidle P , White B , Wills D , Young SA , Hoots BE .
Ann Epidemiol 2019 34 12-17

PURPOSE: To investigate HIV transmission potential from a cluster of HIV infections among men who have sex with men to persons who inject drugs in 15 West Virginia counties. These counties were previously identified as highly vulnerable to rapid HIV dissemination through injection drug use (IDU) associated with high levels of opioid misuse. METHODS: We interviewed persons with 2017 HIV diagnoses about past-year risk behaviors and elicited sexual, IDU, and social contacts. We tested contacts for HIV and assessed risk behaviors. To determine HIV transmission potential from persons with 2017 diagnoses to persons who inject drugs, we assessed viral suppression status, HIV status of contacts, and IDU risk behaviors of persons living with HIV and contacts. RESULTS: We interviewed 78 persons: 39 with 2017 diagnoses and 39 contacts. Overall, 13/78 (17%) injected drugs in the past year. Of 19 persons with 2017 diagnoses and detectable virus, 9 (47%) had more than or equal to 1 sexual or IDU contacts of negative or unknown HIV status. During the past year, 2/9 had injected drugs and shared equipment, and 1/9 had more than or equal to 1 partner who did so. CONCLUSIONS: We identified IDU risk behavior among persons with 2017 diagnoses and their contacts. West Virginia HIV prevention programs should continue to give high priority to IDU harm reduction.
TOP